The National Human Rights Commission (NHRC) has asked the Kerala government to expedite relief measures in the form of financial and medical assistance to victims affected by the indiscriminate use of pesticide Endolsulfan, particularly in Kasaragod district. The commission directed the State government to make use of the services of a charitable trust which had volunteered to set up special schools and hospitals for Endosulfan victims. The NHRC held a meeting here...

Tobacco is a silent killer and the single largest cause of preventable disease including cancer, heart attacks, chronic obstructive lung disease and asthma. According to World Health Organisation, tobacco killed 100 million people in the 20th Century and will kill a billion people (ten times more) in the 21st. Deaths due to tobacco in India are expected to rise from 1.4 per cent in 1990 to 13.3 per cent in 2020....

INDIA will soon be the first country to commercially cultivate biofortified pearl millet, or bajra. The crop has been biofortified to improve its iron and zinc nutrients, and will be released in 2012 by HarvestPlus, a global alliance of research and implementing agencies. To be distributed in Rajasthan, Maharashtra, Gujarat and Uttar Pradesh, the crop has been developed by HarvestPlus’ sister concern International Crops Research Institute for the Semi-Arid Tropics (ICRISAT)....

India’s drug regulator has refused to disclose key information about a controversial government study that provided Indian girls a vaccine designed to protect them from cervical cancer, amplifying suspicions about the study’s objectives. The Drug Controller General of India (DCGI) has refused to release for public scrutiny the study’s protocols, which are expected to contain information about its purpose and methodology, a set of health activists said yesterday. The Union government had...

Rules out blanket ban on or approval of such studies ‘HPV vaccination should supplement cervical cancer screening programme' The three-member committee, set up to probe the alleged irregularities in conducting studies using human papillomavirus (HPV) vaccine by PATH in India, has identified several deficiencies in the planning and implementation of the project leading “to a crisis requiring suspension of the study,” but has fallen short of fixing responsibility on any individual or...